Cardiology General
RSSArticles
-
Clopidogrel pricey, but may edge aspirin
-
Profiling moves from defense to offense
-
Reteplase achieves patency, reduces mortality
-
Clot-busters nearly equal, GUSTO report shows
-
Reteplase designed for use in the field
-
Reteplase is an early prognostic indicator
-
Avoid Trouble: Choose Reteplase Candidates with Care
-
There’s a revolution in AMI care: Reteplase could save time and lives
-
EBCT reimbursement is, at best, dicey
-
Middletown team refines its system